TY  - CONF 
AU  - Sanchez-Piedra, C.
AU  - Prior-Espanol, A.
AU  - Gonzalez, M. F.
AU  - Colazo, M.
AU  - Ruiz-Montesinos, D.
AU  - Perez-Vera, Y.
AU  - Ortiz, A.
AU  - Bustabad, S.
AU  - Vela-Casasempere, P.
AU  - Rojas-Gimenez, M.
AU  - Sanchez-Alonso, F.
AU  - Diaz-Gonzalez, F.
AU  - Gómez-Reino Carnota, Juan Jesús
PY  - 2019
SN  - 0003-4967
UR  - http://hdl.handle.net/20.500.11940/15730
AB  - Background: During the last 15 years, the comprehensive understanding of the safety, effectiveness, expanding access, and availability of new biologic disease-modifying antirheumatic drugs (bDMARDs) has likely contributed to the pattern of use of...
LA  - eng
TI  - Changing pattern of the use of biologic disease modifying antirheumatic drugs in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis
DO  - 10.1136/annrheumdis-2019-eular.3181
KW  - CHUS
VL  - 78
ER  -